Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

NIH × Ureteral Neoplasms × Cystoscopy × Clear all

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Urinary Bladder Neoplasms 6 Ureteral Neoplasms 1 Muscle Invasive Bladder Urothelial Carcinoma 1 Carcinoma, Transitional Cell 1 Carcinoma in Situ 1

Interventions

Specimen Handling 6 Magnetic Resonance Spectroscopy 4 Gemcitabine 3 Biopsy 3 eribulin 2 cabozantinib 2 atezolizumab 2 pembrolizumab 1 erdafitinib 1 enfortumab vedotin 1 carotuximab 1 avelumab 1 Watchful Waiting 1 Platinum 1 Observation 1 Nivolumab 1 Lenalidomide 1 Ipilimumab 1 Interleukin-7 1 Immunoglobulin G 1 Disulfides 1 Cystoscopy 1 Contrast Media 1 Cisplatin 1 Carboplatin 1 CTLA-4 Antigen 1 Bortezomib 1 Bevacizumab 1 Arsenic Trioxide 1 1,2-diaminocyclohexaneplatinum II citrate 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03244384 2026-03-19

AMBASSADOR

National Cancer Institute (NCI)

Phase 3 Active not recruiting

Ureteral Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡